Search research articles
Contact Us
Filters
Showing results (71-80 of 127) with videos related to
Page
of 13
Sort By:
Neuro-Oncology
|
April 16, 2025
Can baseline 18F-FDG PET/CT predict the prognosis of primary CNS lymphoma?
Huiying Zhu, Yaping Luo, Wei Zhang, et al.
Nuclear Medicine Communications
|
May 15, 2024
Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [ 68 Ga]Ga-pentixafor in patients with Waldenström macroglobulinemia and smoldering disease
Qingqing Pan, Xinxin Cao, Jian Li, et al.
Diagnostics (Basel, Switzerland)
|
March 11, 2023
<sup>68</sup>Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease
Qingqing Pan, Yaping Luo, Xinxin Cao, et al.
Clinical Nuclear Medicine
|
May 10, 2018
Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia
Yaping Luo, Qingqing Pan, Jun Feng, et al.
Clinical Nuclear Medicine
|
May 10, 2018
Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC
Yaping Luo, Ling Wang, Qingqing Pan, et al.
Medicine
|
September 21, 2017
Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement: Two case reports and literature review
Yaping Luo, Guilan Hu, Yanru Ma, et al.
Nuclear Medicine Communications
|
September 14, 2020
18F-FDG PET/computed tomography may predict the outcome of newly diagnosed indolent non-Hodgkin lymphoma in patients managed with initial 'watch-and-wait' approach
Yaping Luo, Ying Zhang, Qingqing Pan, et al.
Clinical Nuclear Medicine
|
December 10, 2015
68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma
Yaping Luo, Naishi Li, Dale O Kiesewetter, et al.
Medicine
|
June 21, 2018
Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
Qiao Yang, Yumo Zhao, Chen Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 19, 2019
<sup>68</sup>Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to <sup>18</sup>F-FDG PET/CT
Yaping Luo, Xinxin Cao, Qingqing Pan, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 127) with videos related to
Sort By:
Page
of 13
Neuro-Oncology
|
April 16, 2025
Can baseline 18F-FDG PET/CT predict the prognosis of primary CNS lymphoma?
Huiying Zhu, Yaping Luo, Wei Zhang, et al.
Nuclear Medicine Communications
|
May 15, 2024
Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [ 68 Ga]Ga-pentixafor in patients with Waldenström macroglobulinemia and smoldering disease
Qingqing Pan, Xinxin Cao, Jian Li, et al.
Diagnostics (Basel, Switzerland)
|
March 11, 2023
<sup>68</sup>Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease
Qingqing Pan, Yaping Luo, Xinxin Cao, et al.
Clinical Nuclear Medicine
|
May 10, 2018
Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia
Yaping Luo, Qingqing Pan, Jun Feng, et al.
Clinical Nuclear Medicine
|
May 10, 2018
Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC
Yaping Luo, Ling Wang, Qingqing Pan, et al.
Medicine
|
September 21, 2017
Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement: Two case reports and literature review
Yaping Luo, Guilan Hu, Yanru Ma, et al.
Nuclear Medicine Communications
|
September 14, 2020
18F-FDG PET/computed tomography may predict the outcome of newly diagnosed indolent non-Hodgkin lymphoma in patients managed with initial 'watch-and-wait' approach
Yaping Luo, Ying Zhang, Qingqing Pan, et al.
Clinical Nuclear Medicine
|
December 10, 2015
68Ga-NOTA-Exendin-4 PET/CT in Localization of an Occult Insulinoma and Appearance of Coexisting Esophageal Carcinoma
Yaping Luo, Naishi Li, Dale O Kiesewetter, et al.
Medicine
|
June 21, 2018
Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib
Qiao Yang, Yumo Zhao, Chen Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 19, 2019
<sup>68</sup>Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to <sup>18</sup>F-FDG PET/CT
Yaping Luo, Xinxin Cao, Qingqing Pan, et al.
Page
of 13